ABSTRACT
Citrinin (CIT) is a nephrotoxic mycotoxin produced by Aspergillus, Penicillium, and Monascus genera. It appears as a contaminant in grains, fruits, and spices. After oral exposure to CIT, its major urinary metabolite, dihydrocitrinone (DHC) is formed, which can be detected in human urine and blood samples. Cyclodextrins (CDs) are ring-shaped molecules built up from glucose units. CDs can form host-guest type complexes with several compounds, including mycotoxins. In this study, the complex formation of DHC with native and chemically modified beta- and gamma-cyclodextrins was tested at a wide pH range, employing steady-state fluorescence spectroscopic and modeling studies. The weakly acidic environment favors the formation of DHC-CD complexes. Among the CDs tested, the quaternary-ammonium-γ-cyclodextrin (QAGCD) formed the most stable complexes with DHC. However, the quaternary-ammonium-ß-cyclodextrin (QABCD) induced the strongest enhancement in the fluorescence signal of DHC. Our results show that some of the chemically modified CDs are able to form stable complexes with DHC (logK = 3.2-3.4) and the complex formation can produce even a 20-fold increase in the fluorescence signal of DHC. Considering the above-listed observations, CD technology may be a promising tool to increase the sensitivity of the fluorescence detection of DHC.
Subject(s)
Citrinin/analogs & derivatives , Cyclodextrins/chemistry , Algorithms , Citrinin/chemistry , Models, Theoretical , Molecular Structure , Spectrometry, Fluorescence , ThermodynamicsABSTRACT
Citrinin (CIT) is a nephrotoxic mycotoxin produced by Penicillium, Monascus, and Aspergillus species. CIT appears as a contaminant in cereals, cereal-based products, fruits, nuts, and spices. During the biotransformation of CIT, its major urinary metabolite dihydrocitrinone (DHC) is formed. Albumin interacts with several compounds (including mycotoxins) affecting their tissue distribution and elimination. CIT-albumin interaction is known; however, the complex formation of DHC with albumin has not been reported previously. In this study, we aimed to investigate the interaction of DHC with albumin, employing fluorescence spectroscopy, circular dichroism, and molecular modeling studies. Furthermore, species differences and thermodynamics of the interaction as well as the effects of albumin on the acute in vitro toxicity of DHC and CIT were also tested. Our main observations/conclusions are as follows: (1) Fluorescence signal of DHC is strongly enhanced by albumin. (2) Formation of DHC-albumin complexes is supported by both fluorescence spectroscopic and circular dichroism studies. (3) DHC forms similarly stable complexes with human albumin (K~105 L/mol) as CIT. (4) DHC-albumin interaction did not show significant species differences (tested with human, bovine, porcine, and rat albumins). (5) Based on modeling studies and investigations with site markers, DHC occupies the Heme binding site (subdomain IB) on human albumin. (6) The presence of albumin significantly decreased the acute in vitro cytotoxic effects of both DHC and CIT on MDCK cell line.
Subject(s)
Citrinin/analogs & derivatives , Mycotoxins/metabolism , Poisons/metabolism , Serum Albumin/metabolism , Animals , Cattle , Circular Dichroism , Citrinin/metabolism , Humans , Molecular Dynamics Simulation , Protein Binding , Rats , Spectrometry, Fluorescence , SwineABSTRACT
The analysis of the nephrotoxic mycotoxin citrinin in food, feed, and physiological samples is still challenging. Nowadays, liquid chromatography coupled with mass spectrometry is the method of choice for achieving low limits of detection. But matrix effects can present impairments for this method. Stable isotope dilution analysis can prevent some of these problems. Therefore, a stable isotopically labeled standard of citrinin for use in stable isotope dilution analysis was synthesized on large scale. The improved diastereoselective total synthetic strategy offered the possibility to introduce three 13C-labels in two steps by ortho-toluate anion chemistry. This led to a mass difference of 3 Da, sufficient for preventing spectral overlap. Additionally, a stable isotopically labeled form of dihydrocitrinone, the main urinary metabolite of citrinin, was synthesized with the same mass difference. This was achieved by a sequence of cyclisation, oxidation, deprotection, and carboxylation reactions starting from a protected intermediate of the labeled citrinin synthesis. Thus, this method also offers a complete way to synthesize dihydrocitrinone from citrinin on large scale.
Subject(s)
Carbon Isotopes , Citrinin/analogs & derivatives , Citrinin/chemical synthesis , Citrinin/metabolism , Carbon Isotopes/chemistry , Chromatography, High Pressure Liquid , Citrinin/analysis , Citrinin/chemistry , Magnetic Resonance Spectroscopy , Models, Molecular , Molecular Structure , Mycotoxins/analysis , Mycotoxins/chemical synthesis , Mycotoxins/chemistry , Mycotoxins/metabolism , Staining and Labeling , Tandem Mass SpectrometryABSTRACT
(18)O labeling is a well-known method for the stable isotope labeling of proteins and peptides. This study describes a modified procedure for using (18)O labeling on small molecules. Fumonisin B1, a worldwide occurring mycotoxin, which is routinely analyzed by HPLC-MS/MS, was chosen as model compound. (18)O labeling was achieved by acid-catalyzed oxygen exchange from H2(18)O. A mixture of different isotopologues was obtained from the exchange, which, however, could be used as an internal standard for HPLC-MS/MS analysis. The identity of the (18)O-labeled fumonisin B1 was confirmed by NMR and HRMS measurements. The applicability as internal standard has been verified by comparison of results obtained from the method described in this paper to results obtained by reference methods. The presented method is of special interest as the (18)O labeling can be generally applied to a large group of small molecules containing carboxylic groups.
